Regulations, China Impact and Geopolitics were the top themes in 2020 for Japanese companies to reduce dependency on Chi...
AstraZeneca signed a deal with Beijing-based Shenzhen Kangtai Biological Products (BioKangtai) ...
GenScript Biotech Corporation (“GenScript”, Stock Code: 1548.HK), a leading global biotechnology company tod...
Johnson & Johnson on 5 August 2020 announced it's Janssen Pharmaceutical Companies have entered into an agreeme...
Australia's The Centre for Digestive Disease (CDD) Medical Director Professor Thomas Borody MB, BS, BSc(Med), MD, PhD, D...
The Asian Development Bank (ADB) is providing a $1.5 billion loan to support the Government of Thailand’s response...
Sanofi and GSK are in advanced discussions, with the European Commission (EC) for the supply of up to 300 million doses ...
Recently, members of the COVID R&D Alliance AbbVie, Inc. (ABBV), Amgen Inc. (AMGN), and Takeda Pharmaceutical Co. Lt...
Informa Connect Singapore recently conducted its first live webinar to complement the main conference offering. Hosted a...
Vaccine manufacturers seeking listing on the National Immunisation Program (NIP) Schedule must ask for advice from ...
Brain Navi, a biotechnology startup based in Taiwan's Hsinchu's Biomedical Science Park, has developed a ...
Pfizer Inc. and BioNTech SE have announced an agreement with the Ministry of Health, Labour and Welfare (MHLW) in Japan ...
Clinician-scientists at Nanyang Technological University, Singapore’s (NTU Singapore) Lee Kong Chian School of Med...
Australia based Atomo Diagnostics has announced that it has signed a binding agreement with US-based diagnostics special...
South Korean firm Seegene, Inc. has announced that U.S. Food and Drug Administration (FDA) has further expanded the emer...
Melbourne-based Affinity Biosciences Pty Ltd (Affinity) has lodged a pre-publication submission to the scientific journa...
Tychan, a Singapore-based clinical-stage biotechnology company focused on developing life-saving treatments through disr...
New Zealand's Auckland-based biotechnology company Pictor is embarking on a NZ$2.5 million fundraising round to enable i...
